Page 2 - Symphony Ventures News Today

Big data is transforming the real estate industry. Real estate developers and investors are able to now integrate disconnected data like never before to understand things like a location’s risks, opportunities, and pricing. For example, properties within a quarter-mile of two specialty grocery store leads to higher property values but being within four of these stores correlates to lower pricing. An insight like this could be uncovered manually but it would take countless hours of sorting th...

Kaia Health, a NYC-based digital therapeutics company, raised a $75m Series C funding round. The round was led by an unnamed growth equity fund with participation from existing investors Optum Ventures, Eurazeo, capital300, Balderton Capital, Heartcore Capital, Symphony Ventures (the investment vehicle of golf legend Rory McIlroy) and A Round Capital. The company, which has raised a total of $125m to date, intends to use the funds to grow its commercial team, accelerate product and partnership...

Kaia Health Raises Funds, Plans Expansion Kaia Health announces it has raised $75 million in Series C funding (total raised to date: $125 million) to expand its clinical capabilities and transform the treatment path for musculoskeletal (MSK) and chronic obstructive pulmonary disease (COPD) care in the US and Europe. Fundraising was led by an unnamed leading growth equity fund with support from existing investors, including Optum Ventures, Eurazeo, capital300, Balderton Capital, Heartcore Capit...

Published: Apr 29, 2021 By Alex Keown Less than one year after  launching, Ohio-based Forge Biologics  secured $120 million in a Series B financing round to support the clinical development of its gene therapy program for rare diseases, including the typically fatal Krabbe disease. In an announcement this morning, Forge said the proceeds from the Series B program will be used to accelerate the expansion of its AAV manufacturing CDMO capabilities with cGMP production capacity and ope...

April 29, 2021 April 29, 2021 | Illumina joins the Gates Foundation in a global pathogen genomics initiative, new money for immune profiling, and Benchling nets $200M for their cloud platform.   $375M: Fund for Growth-Stage Medtech, Digital Health  Endeavour Vision has closed Endeavour Medtech Growth II (EMG II) LP at USD 375 million in capital commitments. The fund will pursue the same strategy as its predecessor: to support growth-stage medtech and digital health innovations th...

Digital Therapeutics Startup Kaia Health Raises $75M to Optimize MSK & COPD Care What You Should Know: – Digital therapeutics company, Kaia Health, has raised $75M Series C round (total: $125M) to expand clinical capabilities and transform the treatment path for Musculoskeletal (MSK) and Chronic obstructive pulmonary disease (COPD) care in the U.S. and Europe. – The Series C round was led by an unnamed leading growth equity fund with support from existing investors, including Optum Vent...

Kaia Health grabs $75M on surging interest in its virtual therapies for chronic pain and COPD New York headquartered Kaia Health, which offers AI-assisted digital therapies via a mobile app for chronic pain related to musculoskeletal (MSK) disorders and for Chronic Obstructive Pulmonary Disease (COPD), has raised a $75 million Series C. The round was led by an unnamed leading growth equity fund with support from existing investors, including Optum Ventures, Eurazeo, 3VC, Balderton Capital, Hear...

April 1, 2021 By Bio-IT World Staff April 1, 2021 | New investment funds for late-stage companies and public health. Next-gen genomic medicines and single-cell multiomics get cash, and PatientsLikeMe raises a new round of funding to expand.   $969M Investment Fund for Early to Late-Stage Companies Foresite Capital, a multi-stage healthcare and life sciences investment firm, has announced its fifth and largest fundraise with $969 million in capital commitments, significantly oversu...